Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$13.48
-0.4%
$13.20
$11.82
$28.00
$9.22B1.048.30 million shs5.76 million shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$241.65
-1.0%
$235.54
$211.43
$387.99
$6.64B0.93409,607 shs297,188 shs
Bruker Corporation stock logo
BRKR
Bruker
$41.20
-1.4%
$38.62
$34.10
$72.94
$6.33B1.161.69 million shs1.54 million shs
Revvity, Inc. stock logo
PKI
Revvity
$127.73
$113.46
$170.00
$14.57B1.1851,117 shs1.63 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
-0.49%+0.22%+4.42%-14.62%-36.42%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-0.96%+2.43%+6.57%+0.70%-11.52%
Bruker Corporation stock logo
BRKR
Bruker
-1.44%+6.38%+12.48%+2.03%-35.43%
Revvity, Inc. stock logo
PKI
Revvity
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avantor, Inc. stock logo
AVTR
Avantor
4.9733 of 5 stars
4.25.00.03.22.83.32.5
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.8904 of 5 stars
3.45.00.04.23.82.51.9
Bruker Corporation stock logo
BRKR
Bruker
4.9023 of 5 stars
4.21.01.73.81.85.01.9
Revvity, Inc. stock logo
PKI
Revvity
3.9503 of 5 stars
0.00.01.73.51.11.74.4
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avantor, Inc. stock logo
AVTR
Avantor
2.46
Hold$18.8840.02% Upside
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.75
Moderate Buy$324.2534.18% Upside
Bruker Corporation stock logo
BRKR
Bruker
2.40
Hold$52.8928.37% Upside
Revvity, Inc. stock logo
PKI
Revvity
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest AVTR, PKI, BIO, and BRKR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Bruker Corporation stock logo
BRKR
Bruker
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$61.00 ➝ $50.00
6/9/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$260.00 ➝ $245.00
5/22/2025
Bruker Corporation stock logo
BRKR
Bruker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold$50.00 ➝ $40.00
5/8/2025
Bruker Corporation stock logo
BRKR
Bruker
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$57.00 ➝ $45.00
5/8/2025
Bruker Corporation stock logo
BRKR
Bruker
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$50.00 ➝ $46.00
5/8/2025
Bruker Corporation stock logo
BRKR
Bruker
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$50.00 ➝ $45.00
5/8/2025
Bruker Corporation stock logo
BRKR
Bruker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$57.00 ➝ $48.00
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$355.00 ➝ $310.00
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$400.00 ➝ $350.00
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$409.00 ➝ $392.00
4/29/2025
Avantor, Inc. stock logo
AVTR
Avantor
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avantor, Inc. stock logo
AVTR
Avantor
$6.78B1.35$1.60 per share8.41$8.75 per share1.54
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.57B2.56$10.29 per share23.48$234.52 per share1.03
Bruker Corporation stock logo
BRKR
Bruker
$3.37B1.85$3.54 per share11.64$11.85 per share3.48
Revvity, Inc. stock logo
PKI
Revvity
$3.31B0.00N/A9.88$58.49 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avantor, Inc. stock logo
AVTR
Avantor
$711.50M$1.0412.9611.231.4410.70%11.93%5.50%7/25/2025 (Estimated)
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$1.84B-$76.20N/A19.41N/A-85.16%4.32%3.03%7/30/2025 (Estimated)
Bruker Corporation stock logo
BRKR
Bruker
$113.10M$0.5279.2313.082.812.31%19.47%5.95%8/5/2025 (Estimated)
Revvity, Inc. stock logo
PKI
Revvity
$569.18M$7.6815.010.000.5028.94%11.17%5.83%N/A

Latest AVTR, PKI, BIO, and BRKR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/25/2025Q2 2025
Avantor, Inc. stock logo
AVTR
Avantor
$0.25N/AN/AN/A$1.67 billionN/A
5/7/2025Q1 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.46$0.47+$0.01$0.11$763.83 million$801.40 million
5/1/2025Q1 2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$1.73$2.54+$0.81$2.29$573.01 million$585.40 million
4/25/2025Q1 2025
Avantor, Inc. stock logo
AVTR
Avantor
$0.23$0.23N/A$0.09$1.61 billion$1.58 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Bruker Corporation stock logo
BRKR
Bruker
$0.200.49%N/A38.46%N/A
Revvity, Inc. stock logo
PKI
Revvity
$0.280.24%N/A3.65%N/A

Latest AVTR, PKI, BIO, and BRKR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/12/2025
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.5%6/16/20256/16/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avantor, Inc. stock logo
AVTR
Avantor
0.54
1.12
0.75
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.18
5.99
4.43
Bruker Corporation stock logo
BRKR
Bruker
1.13
1.57
0.74
Revvity, Inc. stock logo
PKI
Revvity
0.48
2.43
2.15

Institutional Ownership

CompanyInstitutional Ownership
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Bruker Corporation stock logo
BRKR
Bruker
79.52%
Revvity, Inc. stock logo
PKI
Revvity
85.22%

Insider Ownership

CompanyInsider Ownership
Avantor, Inc. stock logo
AVTR
Avantor
1.20%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.83%
Bruker Corporation stock logo
BRKR
Bruker
27.30%
Revvity, Inc. stock logo
PKI
Revvity
0.52%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avantor, Inc. stock logo
AVTR
Avantor
13,500681.43 million673.25 millionOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
7,70027.21 million22.36 millionOptionable
Bruker Corporation stock logo
BRKR
Bruker
11,396151.53 million110.16 millionOptionable
Revvity, Inc. stock logo
PKI
Revvity
16,700126.41 million125.76 millionOptionable

Recent News About These Companies

What 9 Analyst Ratings Have To Say About Revvity
Revvity, Inc. (RVTY)
Revvity Inc PKI
Revvity, Inc
Revvity (RVTY) Beats on Q2 Earnings, Lowers '23 EPS View
Revvity (NYSE: PKI)
PerkinElmer Completes Transformation to Become Revvity
J.P. Morgan Keeps Their Hold Rating on PerkinElmer (PKI)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Avantor stock logo

Avantor NYSE:AVTR

$13.48 -0.05 (-0.37%)
As of 06/30/2025 03:58 PM Eastern

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Bio-Rad Laboratories stock logo

Bio-Rad Laboratories NYSE:BIO

$241.65 -2.33 (-0.95%)
As of 06/30/2025 03:58 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bruker stock logo

Bruker NASDAQ:BRKR

$41.20 -0.60 (-1.44%)
As of 06/30/2025 04:00 PM Eastern

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Revvity stock logo

Revvity NYSE:PKI

Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.